448 related articles for article (PubMed ID: 34205075)
1. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.
Stavrou M; Sargiannidou I; Georgiou E; Kagiava A; Kleopa KA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205075
[TBL] [Abstract][Full Text] [Related]
2. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
3. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
4. Common themes in peripheral neuropathy disease genes.
Snipes GJ; Orfali W
Cell Biol Int; 1998 Nov; 22(11-12):815-35. PubMed ID: 10873294
[TBL] [Abstract][Full Text] [Related]
5. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.
Young P; Suter U
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):213-21. PubMed ID: 11690618
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of inherited peripheral neuropathies: who are the actors?
Meuleman J; Timmerman V; Nelis E; De Jonghe P
Acta Neurol Belg; 2000 Sep; 100(3):171-80. PubMed ID: 11098291
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Charcot-Marie-Tooth neuropathies.
Beloribi-Djefaflia S; Attarian S
Rev Neurol (Paris); 2023; 179(1-2):35-48. PubMed ID: 36588067
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
10. Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population.
Gess B; Schirmacher A; Boentert M; Young P
Neuromuscul Disord; 2013 Aug; 23(8):647-51. PubMed ID: 23743332
[TBL] [Abstract][Full Text] [Related]
11. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
12. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
[TBL] [Abstract][Full Text] [Related]
13. Axonal Charcot-Marie-Tooth Disease: from Common Pathogenic Mechanisms to Emerging Treatment Opportunities.
McCray BA; Scherer SS
Neurotherapeutics; 2021 Oct; 18(4):2269-2285. PubMed ID: 34606075
[TBL] [Abstract][Full Text] [Related]
14. Mutation testing in Charcot-Marie-Tooth neuropathy.
Nicholson GA
Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease.
Pisciotta C; Pareyson D
Neuromuscul Disord; 2023 Aug; 33(8):627-635. PubMed ID: 37455204
[TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth neuropathies: Current gene therapy advances and the route toward translation.
Stavrou M; Kagiava A; Sargiannidou I; Georgiou E; Kleopa KA
J Peripher Nerv Syst; 2023 Jun; 28(2):150-168. PubMed ID: 36965137
[TBL] [Abstract][Full Text] [Related]
17. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
18. Charcot-Marie-Tooth disease and related peripheral neuropathies: novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ).
Ekici AB; Schweitzer D; Park O; Lorek D; Rautenstrauss B; Krüger G; Friedl W; Uhlhaas S; Bathke K; Heuss D; Kayser C; Grehl H
Neurogenetics; 2000 Sep; 3(1):49-50. PubMed ID: 11085599
[No Abstract] [Full Text] [Related]
19. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.
Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME;
Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
